Drug Shortage Report for AURO-QUINAPRIL HCTZ
Report ID | 166766 |
Drug Identification Number | 02473321 |
Brand name | AURO-QUINAPRIL HCTZ |
Common or Proper name | QUINAPRIL HCTZ |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE QUINAPRIL |
Strength(s) | 25MG 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 Btl |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-08-12 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-08-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-08-15 | French | Compare |
v1 | 2022-08-15 | English | Compare |
Showing 1 to 2 of 2